{"product_id":"university-of-miami-miami-valves-2023","title":"University of Miami Miami Valves 2023","description":"\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003ch3 class=\"product_title entry-title\"\u003eUniversity of Miami Miami Valves 2023\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eInclude: 105 videos, size: 20.3 GB\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe robust scientific program offered at Miami Valves provides the highest quality education and networking opportunities for all specialists currently using transcatheter therapies to treat valvular and structural heart disease, as well as those looking to expand into this practice area.\u003c\/p\u003e\n\u003cp\u003eFounded by faculty of University of Miami’s centers of excellence and complemented by key opinion leaders from around the world, Miami Valves features powerhouse lectures and case presentations taught by the very best minds in the field.\u003c\/p\u003e\n\u003cp\u003eMiami Valves offers a case-based program delivered by master operators. The Miami Valves case-based structure allows attendees the opportunity to gain tactical knowledge directly from the best in the field.\u003c\/p\u003e\n\u003cp\u003eThis course is directed to physicians specializing in interventional and invasive cardiologists, general cardiologists, cardiovascular surgeons, vascular surgeons, and interventional radiologists.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eLEARNING OBJECTIVES\u003c\/strong\u003e\u003c\/p\u003e\n\u003cdiv class=\"vc_row wpb_row section vc_row-fluid vc_custom_1541280537840 grid_section\"\u003e\n\u003cdiv class=\" section_inner clearfix\"\u003e\n\u003cdiv class=\"section_inner_margin clearfix\"\u003e\n\u003cdiv class=\"wpb_column vc_column_container vc_col-sm-10\"\u003e\n\u003cdiv class=\"vc_column-inner \"\u003e\n\u003cdiv class=\"wpb_wrapper\"\u003e\n\u003cdiv class=\"wpb_text_column wpb_content_element \"\u003e\n\u003cdiv class=\"wpb_wrapper\"\u003e\n\u003cp\u003eBy the conclusion of this activity, participants should be able to:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli class=\"firstItem\"\u003eAppraise new and upcoming technologies in the management of structural heart disease, including, valvular heart disease, stroke prevention, hemodynamic support, cardiomyopathy and high risk-percutaneous coronary intervention to determine their benefit for patients\u003c\/li\u003e\n\u003cli\u003eEvaluate the relative advantages and disadvantages of different strategies in complex cases involving valvulardisease\u003c\/li\u003e\n\u003cli\u003ePresent indications, techniques, outcomes, and complications for transcathetervalve intervention in patients with native valvelesions\u003c\/li\u003e\n\u003cli\u003eCompare FDA approved technologies for TAVR and the scientific data supporting theiruse\u003c\/li\u003e\n\u003cli\u003eExamine best practice techniques for high certainty valveimplantation\u003c\/li\u003e\n\u003cli\u003eAnalyze data and techniques for treatment of bioprosthetic valvedysfunction\u003c\/li\u003e\n\u003cli\u003eEvaluate the rationale, challenges, and necessity of the heart team approach to valvular heart disease, and the functionality of the team within a center ofexcellence\u003c\/li\u003e\n\u003cli\u003eEvoke the changing landscape of percutaneous and surgical techniques of valve repair and replacement\u003c\/li\u003e\n\u003cli\u003eEvaluate the barriers to care in patients with valvular heart disease with specific attention to current gaps in the timely delivery of percutaneous and surgicalinterventions\u003c\/li\u003e\n\u003cli\u003eRecognize the different diagnostic tools and combinations required to accurately diagnose specific structural heart diseases and plan transcathetertherapy\u003c\/li\u003e\n\u003cli\u003eDiscuss rationale and technique of alternative access approach for aorticstenosis\u003c\/li\u003e\n\u003cli\u003eDiscuss investigational valves in the near horizon including their therapeutic advantages and limitations\u003c\/li\u003e\n\u003cli\u003eDescribe the advantages and pitfalls of comprehensive diagnostic techniques for patients with valvular heart disease such as cardiac computed tomography, three-dimensional echocardiography, and complex invasive hemodynamiccatheterization\u003c\/li\u003e\n\u003cli\u003eDiscuss transcatheter treatment options for mitral valvedisease\u003c\/li\u003e\n\u003cli\u003eExplain the clinical data supporting mitral valve leaflet clip approximation for the treatment of mitralregurgitation\u003c\/li\u003e\n\u003cli\u003eDemonstrate and present best practice techniques for mitral valve clipapproximation\u003c\/li\u003e\n\u003cli\u003eExamine alternative investigational devices for the transcatheter treatment of mitral regurgitation\u003c\/li\u003e\n\u003cli\u003ePresent alternatives with transcatheter aortic and pulmonic valve technologies for the treatment of mitraldisease\u003c\/li\u003e\n\u003cli\u003ePresent progress in transcatheter mitral valvereplacement\u003c\/li\u003e\n\u003cli\u003ePresent the techniques and efficacy of transcatheter treatment of mitral prosthetic valve paravalvularleaks\u003c\/li\u003e\n\u003cli\u003eDemonstrate how septal ablation and technologies can improve mitral regurgitation in hypertrophic cardiology.\u003c\/li\u003e\n\u003cli\u003eDiscuss transcatheter treatment options for tricuspid valvediseaseExamine the evidence regarding closure of percutaneous closure of patent foramen ovale for stroke prevention.\u003c\/li\u003e\n\u003cli\u003eExamine the evidence regarding left atrial appendage exclusion for stroke prevention in patients with atrialfibrillation.\u003c\/li\u003e\n\u003cli\u003eExaminethedataandtechniquesforidentificationandassessmentofhemodynamically significant coronary arterylesions.\u003c\/li\u003e\n\u003cli\u003eExamine the data and techniques for coronary imaging and lesioncharacterization.Examine the data and techniques regarding new stent and bio-absorbable scaffolds for percutaneous coronary intervention, as well as devices for coronary intervention facilitation (plaque modification, chronic total occlusion).\u003c\/li\u003e\n\u003cli\u003eExamine the data and techniques for the treatment of in-stent re-stenosis, with emphasizes in new technology.\u003c\/li\u003e\n\u003cli\u003eDiscuss therapeutic alternatives in patients with atrial fibrillation and the data to supportit.\u003c\/li\u003e\n\u003cli\u003eIdentify the indication, techniques and complications for left atrial appendage occlusion in patients with afib.\u003c\/li\u003e\n\u003cli\u003eRecognize the risks and benefits of anticoagulation in patients with atrial fibrillation and other co-morbidities.\u003c\/li\u003e\n\u003cli\u003eIdentify the role for catheter ablation for patients with atrial fibrillation based on the most recent trial\u003c\/li\u003e\n\u003cli\u003eRecognize the pathophysiology of atrial fibrillation and potential for new therapeutic targets.\u003c\/li\u003e\n\u003cli\u003eLearn and evaluate patients for advanced heart failure therapies.\u003c\/li\u003e\n\u003cli\u003eFocused learning related to multi organ transplant and special heart transplant patient population.\u003c\/li\u003e\n\u003cli\u003eEvaluation and basic management of patient with mechanical circulatory support devices including LVADs and Total artificial heart.\u003c\/li\u003e\n\u003cli class=\"lastItem\"\u003eCase based scenarios discussing complex advanced heart failure patients.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e Topics:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e50 Years of Sudden Cardiac Death Prevention – Progress, Promises and Pitfalls.mp4\u003cbr\u003e\nA Complex Case of Severe Bioprosthetic Mitral Stenosis with Spontaneous Clot Formation in the Left Atrium and in Multiorgan Failure- Peripheral VA ECMO.mp4\u003cbr\u003e\nA Complicated Communication – Iatrogenic VSD Closure.mp4\u003cbr\u003e\nA Complicated TAVR Case- Dealing with Balloon Rupture.mp4\u003cbr\u003e\nA Revolutionary Approach to Left Atrial Appendage Closure – LAMINAR – Early Clinical Experience.mp4\u003cbr\u003e\nA Story of a Left-Sided Bioprosthetic Valve Thrombosis.mp4\u003cbr\u003e\nAll in One- Single Access Left Subclavian LM PCI and TAVR.mp4\u003cbr\u003e\nAngioVac to Treat Tricuspid Valve Endocarditis.mp4\u003cbr\u003e\nApical VSD Post Infarction Closure.mp4\u003cbr\u003e\nBarostim and Optimizer in the Management of Heart Failure.mp4\u003cbr\u003e\nBarostim Therapy Surgical Considerations.mp4\u003cbr\u003e\nBetween a Rock and a Hard Place- A Challenging TAVR Case.mp4\u003cbr\u003e\nBetween a Rock and a Hard Place- The Treatment of Calcified Coronary Lesions.mp4\u003cbr\u003e\nBioprosthetic Valve Fracture in Patients Undergoing Valve-in-Valve TAVR for Failed Surgical Valves- Insights from TVT Registry.mp4\u003cbr\u003e\nCardiorenal Syndrome and Renal Protection- Fact vs Fiction.mp4\u003cbr\u003e\nCarotid Body Stimulator – Surgical Considerations.mp4\u003cbr\u003e\nCase Presentation- Double BASILICA.mp4\u003cbr\u003e\nCase Presentation- Tricuspid Mass.mp4\u003cbr\u003e\nCatheter Ablation of Premature Ventricular Complexes for Treatment of Ventricular Fibrillation.mp4\u003cbr\u003e\nCatheter Based Treatment of Structural Heart Disease – Year in Review.mp4\u003cbr\u003e\nCephea Implantation in Native Mitral Valve.mp4\u003cbr\u003e\nChallenging Aortic ViV.mp4\u003cbr\u003e\nCoronary Physiology or Imaging… Or Both.mp4\u003cbr\u003e\nCPVT- The Only Thing that Scares Me in the Inherited Arrhythmia Clinic.mp4\u003cbr\u003e\nCTO Interventions- Is It Worth the Effort..mp4\u003cbr\u003e\nCutting to the Chase- Percutaneous Retrieval of an Aortic Valve Leaflet Cusing Severe Regurgitation and Cardiogenic Shock.mp4\u003cbr\u003e\nDevice-Based Therapy for Prevention of Sudden Cardiac Death in the 21st Century and Beyond.mp4\u003cbr\u003e\nDual Valve-In-Valve Implantation for Surgical Bioprosthesis Failure.mp4\u003cbr\u003e\nEvolution of ICD Therapy- 50 Years of Progress.mp4\u003cbr\u003e\nEvolution of the Management of Cardiogenic Shock.mp4\u003cbr\u003e\nGender and Racial Disparities in SCD Prevention.mp4\u003cbr\u003e\nHeart Failure- Reverse Remodeling. Remission. Recovery..mp4\u003cbr\u003e\nHow To Move Forward With Neuroprotection After PROTECTED TAVR.mp4\u003cbr\u003e\nHow To Optimize TAVR with Cusp Overlap Technique.mp4\u003cbr\u003e\nImplementation of the Shock Team.mp4\u003cbr\u003e\nIntegrating ICE in Transcatheter Tricuspid Intervention.mp4\u003cbr\u003e\nInvestigational Staged Transeptal TMVR 3.mp4\u003cbr\u003e\nInvestigational TMVR-2- The Intrepid Valve.mp4\u003cbr\u003e\nIVL in MAC to Enable TMVR.mp4\u003cbr\u003e\nLAA Closure with 4D ICE Guidance.mp4\u003cbr\u003e\nLAA Device Comparison- AMULET Device.mp4\u003cbr\u003e\nLAAO with the LAmbre Device.mp4\u003cbr\u003e\nLeft Main Bifurcation PCI.mp4\u003cbr\u003e\nLeft Sided AngioVAC, ECMO, ViV TMVR, ViV TAVR.mp4\u003cbr\u003e\nManagement of Commotio Cordis.mp4\u003cbr\u003e\nManagement of High Thrombotic Burden in ACS.mp4\u003cbr\u003e\nManagement of Mitral Paravalvular Leak.mp4\u003cbr\u003e\nMinimalistic Transcaval TAVR.mp4\u003cbr\u003e\nMinimally Invasive Mitral Valve Surgery- State of the Art.mp4\u003cbr\u003e\nMitral Repair – Direct Annuloplasty System.mp4\u003cbr\u003e\nMitral Valve Repair with MitraClip- Complications.mp4\u003cbr\u003e\nMitral Valve-in-Valve \u0026amp; PVL Closure with Concomitant iASD Closure.mp4\u003cbr\u003e\nMyocardial Disease in SCD- The Dynamic Nature of Risk.mp4\u003cbr\u003e\nMyocarditis- A Rising Complication in Young, Healthy Females with Mild COVID-19 Infection.mp4\u003cbr\u003e\nNew Edge to Edge Repair Devices.mp4\u003cbr\u003e\nNew Tricuspid Annuloplasty Device.mp4\u003cbr\u003e\nNewer Transseptal Crossing Techniques.mp4\u003cbr\u003e\nNovel Transeptal Mitral Valve.mp4\u003cbr\u003e\nNovel Ultra Low Profile Geminus TAVR System.mp4\u003cbr\u003e\nOutcomes of Transfemoral Access Transcatheter Aortic Valve Replacement Facilitated by Intravascular Lithotripsy- A Real-World Cohort Analysis.mp4\u003cbr\u003e\nPatient Characteristics and In-Hospital Outcomes Associated with Prolonged Lenght of Stay Post-TAVR.mp4\u003cbr\u003e\nPE Interventions- Patient and Device Selection.mp4\u003cbr\u003e\nPercutaneous Single Access Subclavian TAVR.mp4\u003cbr\u003e\nPercutaneous Treatment of a Subaortic Membrane Using a Self-Expandable TAVR Valve.mp4\u003cbr\u003e\nPharmacogenics and Sudden Cardiac Death.mp4\u003cbr\u003e\nPost TAVR Hemodynamic Collapse – Think Fast \u0026amp; Act Fast.mp4\u003cbr\u003e\nPrecision Transeptal Approach and Mitral PVL Closure.mp4\u003cbr\u003e\nPreservation of the Right Ventricle with Tricuspid Valve Replacement- First-in-Human Experience with a Novel, Asymmetric, Low-Profile Transcatheter Prosthesis.mp4\u003cbr\u003e\nRevascularization and Survival- What’s New in the Guidelines..mp4\u003cbr\u003e\nRisk Stratification for Sudden Cardiac Death- Can We Predict the Future..mp4\u003cbr\u003e\nRole of the Clinician-Scientist in Interventional Device Development- From Concept To Reality.mp4\u003cbr\u003e\nSCD Prevention- Highlights of 35 Years Research Collaboration Between Miami and Oulu Cardiac Research Teams.mp4\u003cbr\u003e\nSelection of Mechanical Circulatory Support in Cardiogenic Shock.mp4\u003cbr\u003e\nSinus of Valsalva Rupture- Transcatheter Treatment.mp4\u003cbr\u003e\nStatus of Non Femoral TAVR.mp4\u003cbr\u003e\nSTEMI with Multivessel CAD- Immediate or Staged Revascularization.mp4\u003cbr\u003e\nStep-By-Step Approach to Cardiogenic Shock.mp4\u003cbr\u003e\nSurgical Aortic Valve Deterioration Treatment With VIV.mp4\u003cbr\u003e\nTAVR 2023- Current State and Futute Directions.. My Crystal Ball for the Next Decade!.mp4\u003cbr\u003e\nTAVR for Aortic Insufficiency.mp4\u003cbr\u003e\nTAVR for Severe AS and Low EF.mp4\u003cbr\u003e\nTAVR in Bicuspid AS.mp4\u003cbr\u003e\nTAVR in Rheumatic AS.mp4\u003cbr\u003e\nTAVR- New Valves.mp4\u003cbr\u003e\nThe Shock of Confirmation Bias.mp4\u003cbr\u003e\nTraining the Structural Interventionalist in the Future.mp4\u003cbr\u003e\nTransapical Mitral Valve Replacement Update.mp4\u003cbr\u003e\nTransseptal Puncture Through Atrial Septal Occluder for Edge-to-Edge Repair.mp4\u003cbr\u003e\nTricuspid Valve Regurgitation After Heart Transplantation- Novelty Treatment.mp4\u003cbr\u003e\nTricuspid Valve- Where Are We..mp4\u003cbr\u003e\nTRISCEND Study One-Year Outcomes- Transfemoral Transcatheter Tricuspid Valve Replacement.mp4\u003cbr\u003e\nUnexpected Complication of a Chronic Total Occlusion PCI.mp4\u003cbr\u003e\nUnmet Needs and Next Step- The Next Generation Watchman FLX.mp4\u003cbr\u003e\nUpdate on ARVC.mp4\u003cbr\u003e\nUpdate on Resuscitation Medicine- Can We Improve Survival..mp4\u003cbr\u003e\nUpdates on Wearable Defibrillators.mp4\u003cbr\u003e\nUpstream TAVR Concept.mp4\u003cbr\u003e\nValve in Valve in a Complex Anatomy.mp4\u003cbr\u003e\nValve-in-MAC TMVR with PVL Closure.mp4\u003cbr\u003e\nValve-in-Valve TAVR with BASILICA and Selective Left Main Coronary Artery Protection in a Patient with High Risk for Coronary Occlusion.mp4\u003cbr\u003e\nVirtual Training in Coronary Intervention.mp4\u003cbr\u003e\nWhat Have I Learned from TAVR Explants.mp4\u003cbr\u003e\nWhat Is Next With Mitral Edge to Edge Repair.mp4\u003cbr\u003e\nWhat’s New in Renal Denervation.mp4\u003cbr\u003e\nWhat’s Next for Mitral Valve Interventions.mp4\u003c\/li\u003e\n\u003c\/ul\u003e\n","brand":"My Store","offers":[{"title":"Default Title","offer_id":42954610507874,"sku":"MED-AMB06991","price":40.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/University-of-Miami-Miami-Valves-2023.png?v=1779380604","url":"https:\/\/meducourse.com\/products\/university-of-miami-miami-valves-2023","provider":"Meducourse","version":"1.0","type":"link"}